Point-of-care testing: state-of-the art and perspectives
Abstract: Point-of-care testing (POCT) is becoming an increasingly popular way to perform laboratory tests closer to the patient. This option has several recognized advantages, such as accessibility, portability, speed, convenience, ease of use, ever-growing test panels, lower cumulative healthcare costs when used within appropriate clinical pathways, better patient empowerment and engagement, and reduction of certain pre-analytical errors, especially those related to specimen transportation. On the other hand, POCT also poses some limitations and risks, namely the risk of lower accuracy and reliability compared to traditional laboratory tests, quality control and connectivity issues, high dependence on operators (with varying levels of expertise or training), challenges related to patient data management, higher costs per individual test, regulatory and compliance issues such as the need for appropriate validation prior to clinical use (especially for rapid diagnostic tests; RDTs), as well as additional preanalytical sources of error that may remain undetected in this type of testing, which is usually based on whole blood samples (i.e., presence of interfering substances, clotting, hemolysis, etc.). There is no doubt that POCT is a breakthrough innovation in laboratory medicine, but the discussion on its appropriate use requires further debate and initiatives. This collective opinion paper, composed of abstracts of the lectures presented at the two-day expert meeting “Point-Of-Care-Testing: State of the Art and Perspective” (Venice, April 4–5, 2024), aims to provide a thoughtful overview of the state-of-the-art in POCT, its current applications, advantages and potential limitations, as well as some interesting reflections on the future perspectives of this particular field of laboratory medicine.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Point-of-care testing: state-of-the art and perspectives ; volume:63 ; number:1 ; year:2025 ; pages:35-51 ; extent:17
Clinical chemistry and laboratory medicine ; 63, Heft 1 (2025), 35-51 (gesamt 17)
- Urheber
-
Plebani, Mario
Nichols, James H.
Luppa, Peter B.
Greene, Dina
Sciacovelli, Laura
Shaw, Julie
Khan, Adil I.
Carraro, Paolo
Freckmann, Guido
Dimech, Wayne
Zaninotto, Martina
Spannagl, Michael
Huggett, Jim
Kost, Gerald J.
Trenti, Tommaso
Padoan, Andrea
Thomas, Annette
Banfi, Giuseppe
Lippi, Giuseppe
- DOI
-
10.1515/cclm-2024-0675
- URN
-
urn:nbn:de:101:1-2412011509347.227098112962
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2002, 15:45 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Plebani, Mario
- Nichols, James H.
- Luppa, Peter B.
- Greene, Dina
- Sciacovelli, Laura
- Shaw, Julie
- Khan, Adil I.
- Carraro, Paolo
- Freckmann, Guido
- Dimech, Wayne
- Zaninotto, Martina
- Spannagl, Michael
- Huggett, Jim
- Kost, Gerald J.
- Trenti, Tommaso
- Padoan, Andrea
- Thomas, Annette
- Banfi, Giuseppe
- Lippi, Giuseppe